Product Information

DASATINIB 100 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $26.1835 per EA under NDC 68001066404. Its NADAC has been published 40 times since Nov 19, 2025.

FDA first approved this application on Mar 3, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DASATINIB 100 MG TABLET

dasatinib
$26.1835per EA

Strength

100 mg/1

NDC

68001066404

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DASATINIB

Approval Type

Generic (ANDA)

FDA Application

ANDA217217

FDA Approved

3/3/2025

TE Code

AB

On Market Since

9/29/2025

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor
Protein Kinase Inhibitors

Price Statistics

The NADAC for DASATINIB 100 MG TABLET has been published 40 times since Nov 19, 2025, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.

Current price$26.1835 per EA
All-time high$191.7363 (Dec 10, 2025)
All-time low$26.1835 (Aug 19, 2026)
52-week high$191.7363
52-week low$26.1835
Median price$29.1857
Average price$44.6838
Largest weekly change-84.2% (Dec 17, 2025)
Weeks tracked40
Tracking sinceNov 19, 2025

Price History

1W

-0.9%

1M

-0.9%

3M

-3.0%

6M

-12.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

-86.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DASATINIB 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DASATINIB 100 MG TABLET, manufactured by BluePoint Laboratories, is $26.1835 per EA (NDC 68001066404), effective Aug 19, 2026.

How has the price of DASATINIB 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for DASATINIB 100 MG TABLET has declined 86.3%. It has been tracked across 40 weekly CMS publications since Nov 19, 2025.

What are the highest and lowest recorded NADAC prices for DASATINIB 100 MG TABLET?

Since Nov 19, 2025, the NADAC for DASATINIB 100 MG TABLET has ranged from a low of $26.1835 (Aug 19, 2026) to a high of $191.7363 (Dec 10, 2025), with a median of $29.1857 per EA.

Are there cheaper alternatives to DASATINIB 100 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DASATINIB 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DASATINIB 100 MG TABLET?

DASATINIB 100 MG TABLET (NDC 68001066404) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.